跳至主要内容
临床试验/NCT05629403
NCT05629403已完成不适用

Women's Hospital of Nanjing Medical University

Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
84
试验地点
1
主要终点
insulin

研究概览

简要总结

Breastfeeding could effectively be associated with a lower risk of future type 2 diabetes (T2D) in women with gestational diabetes mellitus (GDM), but the short-term protective impact of puerperal breastfeeding on maternal metabolic recovery of GDM women remains unascertained. The investigators recruited GDM participants at 6-9 weeks postpartum and retrieved clinical diagnoses of GDM from electronic medical records. Feeding patterns were collected via phone calls. Glucose metabolism parameters and lipid profiling were performed on fasting plasma samples collected from patients 6-9 weeks postpartum (20 breastfeeding cases vs. 15 formula feeding cases).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-35 years old;
  • gestational age greater than 37 weeks;
  • Body Mass Index (BMI) before pregnancy 18.5-28kg/m2;
  • Have normal listening and speaking skills, can communicate, and are willing to participate in this study.

排除标准

  • abnormal glucose metabolism or diabetes has been diagnosed before pregnancy;
  • assisted reproduction;
  • GDM patients requiring drug treatment;
  • The use of blood lipid regulation drugs;
  • other pregnancy complications and complications;
  • Suffering from heart, malignant tumor, kidney and other major organ diseases;
  • associated with neurological dysfunction and cognitive impairment;
  • Failure to cooperate with follow-up observers.

结局指标

主要结局

insulin

时间窗: At 6-8 weeks postpartum

insulin (mU/L) determined with human ELISA kits

HOMA-IR

时间窗: At 6-8 weeks postpartum

fasting glucose and fasting glucose will be combined to report HOMA-IR

glucose

时间窗: At 6-8 weeks postpartum

glucose (mmol/L) determined with human ELISA kits

c-peptide

时间窗: At 6-8 weeks postpartum

c-peptide (ng/m) determined with human ELISA kits

次要结局

未报告次要终点

研究者

发起方
Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xirong Guo

Professor

Nanjing Medical University

研究点 (1)

Loading locations...

相似试验